Medicenna Therapeutics Stock Forecast - Simple Moving Average

MDNA Stock  CAD 0.94  0.01  1.05%   
The Simple Moving Average forecasted value of Medicenna Therapeutics Corp on the next trading day is expected to be 0.94 with a mean absolute deviation of 0.06 and the sum of the absolute errors of 3.63. Medicenna Stock Forecast is based on your current time horizon. Although Medicenna Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Medicenna Therapeutics' systematic risk associated with finding meaningful patterns of Medicenna Therapeutics fundamentals over time.
As of today the rsi of Medicenna Therapeutics' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Medicenna Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Medicenna Therapeutics Corp, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Medicenna Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(0.07)
EPS Estimate Current Year
(0.24)
EPS Estimate Next Year
(0.37)
Wall Street Target Price
3.875
Using Medicenna Therapeutics hype-based prediction, you can estimate the value of Medicenna Therapeutics Corp from the perspective of Medicenna Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Medicenna Therapeutics Corp on the next trading day is expected to be 0.94 with a mean absolute deviation of 0.06 and the sum of the absolute errors of 3.63.

Medicenna Therapeutics after-hype prediction price

    
  CAD 0.92  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Historical Fundamental Analysis of Medicenna Therapeutics to cross-verify your projections.
As of the 10th of January 2026, Payables Turnover is likely to drop to 0.01. As of the 10th of January 2026, Common Stock Shares Outstanding is likely to grow to about 92.6 M, while Net Loss is likely to drop (11.2 M).

Medicenna Therapeutics Additional Predictive Modules

Most predictive techniques to examine Medicenna price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Medicenna using various technical indicators. When you analyze Medicenna charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A two period moving average forecast for Medicenna Therapeutics is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility.

Medicenna Therapeutics Simple Moving Average Price Forecast For the 11th of January 2026

Given 90 days horizon, the Simple Moving Average forecasted value of Medicenna Therapeutics Corp on the next trading day is expected to be 0.94 with a mean absolute deviation of 0.06, mean absolute percentage error of 0.01, and the sum of the absolute errors of 3.63.
Please note that although there have been many attempts to predict Medicenna Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Medicenna Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Medicenna Therapeutics Stock Forecast Pattern

Backtest Medicenna TherapeuticsMedicenna Therapeutics Price PredictionBuy or Sell Advice 

Medicenna Therapeutics Forecasted Value

In the context of forecasting Medicenna Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Medicenna Therapeutics' downside and upside margins for the forecasting period are 0.01 and 8.97, respectively. We have considered Medicenna Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.94
0.94
Expected Value
8.97
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Medicenna Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Medicenna Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria111.8555
BiasArithmetic mean of the errors -8.0E-4
MADMean absolute deviation0.0605
MAPEMean absolute percentage error0.0461
SAESum of the absolute errors3.63
The simple moving average model is conceptually a linear regression of the current value of Medicenna Therapeutics Corp price series against current and previous (unobserved) value of Medicenna Therapeutics. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future

Predictive Modules for Medicenna Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Medicenna Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.050.928.95
Details
Intrinsic
Valuation
LowRealHigh
0.050.928.95
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.07-0.06-0.06
Details

Other Forecasting Options for Medicenna Therapeutics

For every potential investor in Medicenna, whether a beginner or expert, Medicenna Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Medicenna Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Medicenna. Basic forecasting techniques help filter out the noise by identifying Medicenna Therapeutics' price trends.

Medicenna Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Medicenna Therapeutics stock to make a market-neutral strategy. Peer analysis of Medicenna Therapeutics could also be used in its relative valuation, which is a method of valuing Medicenna Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Medicenna Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Medicenna Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Medicenna Therapeutics' current price.

Medicenna Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Medicenna Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Medicenna Therapeutics shares will generate the highest return on investment. By undertsting and applying Medicenna Therapeutics stock market strength indicators, traders can identify Medicenna Therapeutics Corp entry and exit signals to maximize returns.

Medicenna Therapeutics Risk Indicators

The analysis of Medicenna Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Medicenna Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting medicenna stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Other Information on Investing in Medicenna Stock

Medicenna Therapeutics financial ratios help investors to determine whether Medicenna Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicenna with respect to the benefits of owning Medicenna Therapeutics security.